Brazilian Guideline on Menopausal Cardiovascular Health - 2024

Hersh A, Stefanick M, Stafford R . National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004; 291(1):47-53. DOI: 10.1001/jama.291.1.47. View

Lederman S, Ottery F, Cano A, Santoro N, Shapiro M, Stute P . Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet. 2023; 401(10382):1091-1102. DOI: 10.1016/S0140-6736(23)00085-5. View

Xu M, Amarilla Vallejo A, Cantalapiedra Calvete C, Rudd A, Wolfe C, OConnell M . Stroke Outcomes in Women: A Population-Based Cohort Study. Stroke. 2022; 53(10):3072-3081. DOI: 10.1161/STROKEAHA.121.037829. View

Armeni E, Lambrinoudaki I . Menopause, androgens, and cardiovascular ageing: a narrative review. Ther Adv Endocrinol Metab. 2022; 13:20420188221129946. PMC: 9619256. DOI: 10.1177/20420188221129946. View

Tepper N, Whiteman M, Marchbanks P, James A, Curtis K . Progestin-only contraception and thromboembolism: A systematic review. Contraception. 2016; 94(6):678-700. PMC: 11034842. DOI: 10.1016/j.contraception.2016.04.014. View

Shin J, Han K, Jung J, Park H, Kim W, Huh Y . Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study. Eur Heart J. 2022; 43(40):4148-4157. DOI: 10.1093/eurheartj/ehac364. View

Muka T, Oliver-Williams C, Kunutsor S, Laven J, Fauser B, Chowdhury R . Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis. JAMA Cardiol. 2016; 1(7):767-776. DOI: 10.1001/jamacardio.2016.2415. View

Flores V, Pal L, Manson J . Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment. Endocr Rev. 2021; 42(6):720-752. DOI: 10.1210/endrev/bnab011. View

Faubion S, Shufelt C . Why is everyone talking about menopause?. Maturitas. 2023; 177:107777. DOI: 10.1016/j.maturitas.2023.05.001. View

10.

Handley A, Williams M . The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review. J Am Assoc Nurse Pract. 2014; 27(1):54-61. DOI: 10.1002/2327-6924.12137. View

11.

OKelly A, Michos E, Shufelt C, Vermunt J, Minissian M, Quesada O . Pregnancy and Reproductive Risk Factors for Cardiovascular Disease in Women. Circ Res. 2022; 130(4):652-672. PMC: 8870397. DOI: 10.1161/CIRCRESAHA.121.319895. View

12.

Baber R, Panay N, Fenton A . 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric. 2016; 19(2):109-50. DOI: 10.3109/13697137.2015.1129166. View

13.

Divaris E, Anagnostis P, Gkekas N, Kouidi E, Goulis D . Early menopause and premature ovarian insufficiency may increase the risk of sarcopenia: A systematic review and meta-analysis. Maturitas. 2023; 175:107782. DOI: 10.1016/j.maturitas.2023.05.006. View

14.

Janssen I, Powell L, Matthews K, Jasielec M, Hollenberg S, Bromberger J . Relation of Persistent Depressive Symptoms to Coronary Artery Calcification in Women Aged 46 to 59 Years. Am J Cardiol. 2016; 117(12):1884-9. PMC: 4885775. DOI: 10.1016/j.amjcard.2016.03.035. View

15.

Wenger N, Arnold A, Merz C, Cooper-DeHoff R, Ferdinand K, Fleg J . Hypertension Across a Woman's Life Cycle. J Am Coll Cardiol. 2018; 71(16):1797-1813. PMC: 6005390. DOI: 10.1016/j.jacc.2018.02.033. View

16.

Hallajzadeh J, Khoramdad M, Izadi N, Karamzad N, Almasi-Hashiani A, Ayubi E . Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies. Menopause. 2018; 25(10):1155-1164. DOI: 10.1097/GME.0000000000001136. View

17.

Assad J, Femia G, Pender P, Badie T, Rajaratnam R . Takotsubo Syndrome: A Review of Presentation, Diagnosis and Management. Clin Med Insights Cardiol. 2022; 16:11795468211065782. PMC: 8733363. DOI: 10.1177/11795468211065782. View

18.

Kaminska M, Schneider-Matyka D, Rachubinska K, Panczyk M, Grochans E, Cybulska A . Menopause Predisposes Women to Increased Risk of Cardiovascular Disease. J Clin Med. 2023; 12(22). PMC: 10672665. DOI: 10.3390/jcm12227058. View

19.

Gurka M, Vishnu A, Santen R, DeBoer M . Progression of Metabolic Syndrome Severity During the Menopausal Transition. J Am Heart Assoc. 2016; 5(8). PMC: 5015287. DOI: 10.1161/JAHA.116.003609. View

20.

Szmuilowicz E, Manson J, Rossouw J, Howard B, Margolis K, Greep N . Vasomotor symptoms and cardiovascular events in postmenopausal women. Menopause. 2011; 18(6):603-10. PMC: 3123435. DOI: 10.1097/gme.0b013e3182014849. View